160 related articles for article (PubMed ID: 38687509)
1. EIF3B stabilizes PCNA by counteracting SYVN1-mediated ubiquitination to serve as a promotor in cholangiocarcinoma.
Huang R; Nie W; Mi L; Yao C; Zhu H
Aging (Albany NY); 2024 Apr; 16(8):7311-7330. PubMed ID: 38687509
[TBL] [Abstract][Full Text] [Related]
2. EIF3B stabilizes PTGS2 expression by counteracting MDM2-mediated ubiquitination to promote the development and progression of malignant melanoma.
Fang P; Han Y; Qu Y; Wang X; Zhang Y; Zhang W; Zhang N; Li G; Ma W
Cancer Sci; 2022 Dec; 113(12):4181-4192. PubMed ID: 36050601
[TBL] [Abstract][Full Text] [Related]
3. Expression of transforming growth factor β1 promotes cholangiocarcinoma development and progression.
Huang CK; Aihara A; Iwagami Y; Yu T; Carlson R; Koga H; Kim M; Zou J; Casulli S; Wands JR
Cancer Lett; 2016 Sep; 380(1):153-62. PubMed ID: 27364974
[TBL] [Abstract][Full Text] [Related]
4. Biological effects of RNAi targeted inhibiting Tiam1 gene expression on cholangiocarcinoma cells.
Cheng W; Liu Y; Zuo Z; Yin X; Jiang B; Chen D; Peng C; Yang J
Int J Clin Exp Pathol; 2015; 8(12):15511-26. PubMed ID: 26884821
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-329-mediated PTTG1 downregulation inactivates the MAPK signaling pathway to suppress cell proliferation and tumor growth in cholangiocarcinoma.
Hu ZG; Zheng CW; Su HZ; Zeng YL; Lin CJ; Guo ZY; Zhong FD; Yuan GD; He SQ
J Cell Biochem; 2019 Jun; 120(6):9964-9978. PubMed ID: 30582202
[TBL] [Abstract][Full Text] [Related]
6. TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma.
Xu F; Zhang S; Liu Z; Gu J; Li Y; Wang L; Mao W; Zhu Q; Shou H; Ge D; Lu C
BMC Cancer; 2019 Sep; 19(1):875. PubMed ID: 31481019
[TBL] [Abstract][Full Text] [Related]
7. Translation initiation factor eIF3b expression in human cancer and its role in tumor growth and lung colonization.
Wang H; Ru Y; Sanchez-Carbayo M; Wang X; Kieft JS; Theodorescu D
Clin Cancer Res; 2013 Jun; 19(11):2850-60. PubMed ID: 23575475
[TBL] [Abstract][Full Text] [Related]
8. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
[TBL] [Abstract][Full Text] [Related]
9. CRL4Cdt2 E3 ubiquitin ligase and proliferating cell nuclear antigen (PCNA) cooperate to degrade thymine DNA glycosylase in S phase.
Shibata E; Dar A; Dutta A
J Biol Chem; 2014 Aug; 289(33):23056-23064. PubMed ID: 24962565
[TBL] [Abstract][Full Text] [Related]
10. Eukaryotic translation initiation factor 3 subunit b is a novel oncogenic factor in prostate cancer.
Xiang P; Sun Y; Fang Z; Yan K; Fan Y
Mamm Genome; 2020 Aug; 31(7-8):197-204. PubMed ID: 32556998
[TBL] [Abstract][Full Text] [Related]
11. Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.
Zhang H; Li Z; Chu B; Zhang F; Zhang Y; Ke F; Chen Y; Xu Y; Liu S; Zhao S; Liang H; Weng M; Wu X; Li M; Wu W; Quan Z; Liu Y; Zhang Y; Gong W
Tumour Biol; 2016 Jun; 37(6):8305-15. PubMed ID: 26729195
[TBL] [Abstract][Full Text] [Related]
12. Effects of EIF3B gene downregulation on apoptosis and proliferation of human ovarian cancer SKOV3 and HO-8910 cells.
Wang L; Ouyang L
Biomed Pharmacother; 2019 Jan; 109():831-837. PubMed ID: 30551537
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA RP11-284P20.2 promotes cell proliferation and invasion in hepatocellular carcinoma by recruiting EIF3b to induce c-met protein synthesis.
Fang QL; Zhou JY; Xiong Y; Xie CR; Wang FQ; Li YT; Yin ZY; Luo GH
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32100822
[TBL] [Abstract][Full Text] [Related]
14. Depletion of STYK1 inhibits intrahepatic cholangiocarcinoma development both in vitro and in vivo.
Chen MY; Zhang H; Jiang JX; Sun CY; Yu C; Tian S
Tumour Biol; 2016 Oct; 37(10):14173-14181. PubMed ID: 27542675
[TBL] [Abstract][Full Text] [Related]
15. RPL35A promotes the progression of cholangiocarcinoma by mediating HSPA8 ubiquitination.
Zhang C; Wang Y; Wu G; Sun N; Bai H; Li X; Han S; Zhou H; Qi R; Zhang J
Biol Direct; 2024 Feb; 19(1):16. PubMed ID: 38395908
[TBL] [Abstract][Full Text] [Related]
16. Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells.
Xu Y; Yao Y; Zhong X; Leng K; Qin W; Qu L; Cui Y; Jiang X
Biochem Biophys Res Commun; 2018 Feb; 496(2):455-461. PubMed ID: 29337065
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma by negatively regulating the Wnt/β-catenin signaling pathway.
Hu X; Tan Z; Yang Y; Yang P
J Gene Med; 2019 May; 21(5):e3085. PubMed ID: 30856284
[TBL] [Abstract][Full Text] [Related]
18. Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis.
Batheja N; Suriawinata A; Saxena R; Ionescu G; Schwartz M; Thung SN
Mod Pathol; 2000 Dec; 13(12):1265-8. PubMed ID: 11144921
[TBL] [Abstract][Full Text] [Related]
19. LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152.
Zhang S; Xiao J; Chai Y; Du YY; Liu Z; Huang K; Zhou X; Zhou W
Dig Dis Sci; 2017 Nov; 62(11):3050-3058. PubMed ID: 28921383
[TBL] [Abstract][Full Text] [Related]
20. E3 ubiquitin ligase FBW7α inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E.
Li M; Ouyang L; Zheng Z; Xiang D; Ti A; Li L; Dan Y; Yu C; Li W
Oncol Rep; 2017 Mar; 37(3):1627-1636. PubMed ID: 28184929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
